CG Oncology, Inc. (CGON) vs Rhythm Pharmaceuticals, Inc. (RYTM)
CG Oncology, Inc. and Rhythm Pharmaceuticals, Inc. are both Biotechnology companies. Rhythm Pharmaceuticals, Inc. is the larger, with a market value of $6.8B against $6.1B — 1.1× the size. CG Oncology, Inc. grew revenue faster over the last twelve months: 840.8% against 53.5%. Rhythm Pharmaceuticals, Inc. has the higher net margin (−87.6% vs −3,602.7%) and the higher return on invested capital (0.00% vs −4,111.6%). Across the 17 metrics below, Rhythm Pharmaceuticals, Inc. leads on 12 and CG Oncology, Inc. on 5.
Valuation
Profitability
| Metric | CGON | RYTM | Biotechnology median |
|---|---|---|---|
| Gross margin | (85.20%) | 89.00% | 65.16% |
| Operating margin | (4,056.18%) | (83.62%) | 0.00% |
| Net margin | (3,602.68%) | (87.62%) | 0.00% |
| Free cash flow margin | (2,879.62%) | (43.91%) | 0.00% |
| Return on equity | (26.41%) | (461.65%) | (57.72%) |
| Return on assets | (25.11%) | (51.91%) | (49.22%) |
| Return on invested capital | (4,111.64%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack